Clinical Trial Participation

Selected news for the healthcare topic - Clinical Trial Participation, collected since 11/2017. Recent stories appear in Nature and clinicalresearchnewsonline.com. This healthcare topic shares news with Food and Drug Administration, Genentech, Clinical Research and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/24/2021 Covid-19 serves as catalyst for effort to diversify clinical trial enrollment MedCity News ... to Allison Kalloo, founder and president of Clinical Ambassador, an organization that helps the life sciences industry diversify study enrollment. She noted that Drug Trials Snapshots , the FDA database that provides demographic data on clinical trial participation , shows that for roughly 75% of drugs approved by the FDA, there are not enough data from minority participants to be statistically significant. She added that the figures are a glaring shortcoming considering ...
4/14/2021 Senators Richard Burr and Ben Cardin Recognized as ASCO Congressional Champions for Cancer Care asco.org ... and securing its inclusion in the end-of-year legislative package that passed Congress in late 2020. The bill improves patient access to clinical trials by guaranteeing coverage of the routine care costs of clinical trial participation for Medicaid enrollees with life-threatening conditions. Medicaid coverage of these costs has been one of ASCO’s top legislative priorities for a number of years and the passage of this bill will ...
4/8/2021 Nobody dares stopping clinical research, not even COVID-19 Nature ... COVID-19), the capacities of the healthcare systems in the affected countries have been put under pressure, and they have quickly reached their limits. In addition to the existing structural and clinical barriers to clinical trial participation , the COVID-19 public health emergency can negatively influence how clinical trials are conducted and impose additional obstacles to patient enrollment and ongoing monitoring in investigative research. With this in mind, international and ...
4/6/2021 Breast Cancer in Women Older Than 80 Years Physicians Weekly Breast Cancer in Women Older Than 80 YearsApr 6, 2021 Breast cancer is the most common cancer among women in the US, affecting one in three female cancers, and is the second leading cause of cancer death. In one pivotal study of clinical trial participation , only 9% of trial participants aged 75 years plus compared to 31% of the overall patient population. For this review, we searched for relevant ...
3/26/2021 US Blacks Underrepresented in Cardiovascular Drug Trials Physicians Weekly ... entity drugs for seven cardiovascular conditions during the study period. There were 187,294 participants enrolled in related clinical trials, including 5,396 Black participants and 155,694 White participants. Black participants represented 2.9 percent of total clinical trial participation (participation to prevalence ratio [PPR], 0.29), ranging from a PPR of 0.52 for Black participants in hypertension drug trials to a PPR of 0.72 in hypercholesterolemia trials. All PPRs were 0.8, indicating underrepresentation ...
3/23/2021 AbbVie Quantifying Burden Of Clinical Trial Participation clinicalresearchnewsonline.com AbbVie Quantifying Burden Of Clinical Trial ParticipationBy Deborah BorfitzMarch 23, 2021 AbbVie is developing a patient burden algorithm to quantify the onus of trial-related procedures on study participants, according to Allam Fakhoury, PharmD, the company’s head of portfolio design and execution, at a presentation he made at last week’s (SCOPE). The pilot scoring system was created using responses to an online survey completed by about ...
3/23/2021 Reltio Launches Enterprise 360 Site Intelligence to Accelerate Clinical Trials tmcnet.com ... Enterprise 360 Site Intelligence. HCOs, HCPs, PIs, and study sites are often connected in many-to-many relationships. Reltio Connected Graph can quickly identify content preferences, influence in a disease area, prescribed products, and clinical trial participation that traditional databases cannot. The graph models interrelationships and dynamic hierarchical information for an at-a-glance view. These insights are valuable.AI provides insight into key considerations for clinical trials. These include ...
3/18/2021 UAB cancer center partner in study to improve participation among Blacks in lung cancer trials - al.com al.com ... other racial group.The project will study and interview many people who play a role in the clinical trial process, from patients to research staff and doctors, to find out what contributes to decreased clinical trial participation among African American patients. The second part of the project will use what was learned to select and test different evidence-based initiatives to increase the participation of African American patients in clinical ...
3/12/2021 Reducing Barriers to Clinical Trial Participation mda.org We're accelerating the delivery of treatments and cures. Reducing Barriers to Clinical Trial Participation Activity Snapshot Saturday, August 1, 2020 Sponsor Information:This program is supported in part by independent educational grants from Biogen and Momenta Pharmaceuticals, Inc. Faculty Children’s Hospital Los Angeles Dr. Robert Baloh Ronald Reagan UCLA Medical Center Dr. Nivedita Jerath Download PowerPoint Presentation Activity Overview:The MDA Medical Education team has partnered with Dr. Leigh ...
3/9/2021 Addressing Disunited Cancer Care thedoctorspost.com ... the other inequities in access to clinical trials extend cross-sectionally through a society based on age, ethnicity, race, and socioeconomic factors. The necessity is to address the economic barriers first.The improvements in clinical trial participation of rural populations are based on understanding, trust, and persistence, which are similarly required to ensure increased representation of minority groups. Despite recent successes in providing access to clinical trials in rural areas ...
3/9/2021 Clinical Trials and Trust appliedclinicaltrialsonline.com OR WAIT null SECS ™ Understanding the role of social determinants on clinical trial participation and trust. The Michael J. Fox Foundation for Parkinson’s Research (MJFF) aims to speed clinical research by removing obstacles that stand in the way of drug development. In pursuit of this mission, the Foundation gathers insights from a wide range of stakeholders and uses these perspectives to enhance clinical trial processes from start to ...
3/2/2021 Craig Lipset is Appointed Chairman of the Trialbee Industry Advisory Board financialbuzz.com ... cofounded and co-Chairs the Decentralized Trials & Research Alliance (DTRA), which roughly 100 leading life science organizations have joined the first few months since it was established. The core mission of DTRA is making clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.A significant barrier to patient participation in clinical research is awareness and access. Trialbee’s patient focused platform is ...
2/17/2021 Transforming Clinical Trials with Real-World Evidence | BCG bcg.com ... reduce the number of patients required in traditional control arms, especially active-comparator or standard-of-care arms, thereby decreasing the study cost, accelerating the speed to result, and boosting the overall attractiveness of clinical trial participation for prospective patients.Indeed, all signs indicate that the use of SCAs is poised to take off. The relevant data is becoming more readily available, and the advanced analytics needed to gain insights ...
2/16/2021 Building A Successful Clinical Trial Engagement Platform, Upcoming Webinar Hosted by Xtalks PRWeb ... designed platform can educate patients about clinical trials while also serving as a recruitment tool. Attendees will learn about the results of market research about what information patients said they value most when considering clinical trial participation and how to build a successful clinical trial engagement platform for your company. Creating such a platform allows sponsors to provide much-needed education about clinical trials, directly address issues that can impact ...
2/15/2021 Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program biomedcentral.com ... findings from a subgroup of Italian patients enrolled in the avelumab EAP. MethodsEligible patients had mMCC and progressive disease following‚Äâ‚â•‚Äâ1 prior line of chemotherapy or were ineligible for chemotherapy or clinical trial participation . Patients received avelumab 10 mg/kg intravenously every 2 weeks. Treating physicians were provided with an initial 3-month supply of avelumab; resupply was permitted if the patient achieved a complete response, partial ...
2/14/2021 Miles College enters partnership seeking equity in COVID-19 vaccinations, clinical research trials yellowhammernews.com ... equity in COVID-19 vaccinations and clinical research trials.Acclinate, a trusted health care solutions provider, integrates culture and technology to educate and engage diverse individuals to make informed decisions about genomic research and clinical trial participation .“Essential to this partnership is the stark realization that the African American community has been historically omitted from significant consideration for clinical trials and research for cures to the most critical public health ...
2/5/2021 Advanced Clinical Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials Business Wire ... trials and research. The “Decentralized Trials & Research Alliance ( DTRA ),” which launched December 10th, 2020, will unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.“We are excited to join DTRA to help shape the innovative approach to clinical trial design and conduct,” ...
2/5/2021 Advanced Clinical Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials financialbuzz.com ... trials and research. The “Decentralized Trials & Research Alliance ( DTRA ),” which launched December 10th, 2020, will unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.“We are excited to join DTRA to help shape the innovative approach to clinical trial design and conduct,” ...
2/3/2021 Miles College, #NOWINCLUDED Partner for Equity in Clinical Research Trials birminghamtimes.com ... in COVID-19 vaccinations and clinical research trials.Acclinate is a trusted health care solutions provider integrating culture and technology to educate and engage diverse individuals to make informed decisions about genomic research and clinical trial participation .“Essential to this partnership is the stark realization that the African American community has been historically omitted from significant consideration for clinical trials and research for cures to the most critical public health ...
1/29/2021 MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS mmsholdings.com ... research. The “Decentralized Trials & Research Alliance ( DTRA ),” which launched on December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.“As a specialized data services and technologies provider, MMS will help guide the life sciences industry into an exciting ...